Alprazolam 2care4 1 mg Depottablett Swedia - Swedia - Läkemedelsverket (Medical Products Agency)

alprazolam 2care4 1 mg depottablett

2care4 aps - alprazolam - depottablett - 1 mg - alprazolam 1 mg aktiv substans; laktosmonohydrat hjälpämne - alprazolam

Alprazolam 2care4 2 mg Depottablett Swedia - Swedia - Läkemedelsverket (Medical Products Agency)

alprazolam 2care4 2 mg depottablett

2care4 aps - alprazolam - depottablett - 2 mg - alprazolam 2 mg aktiv substans; laktosmonohydrat hjälpämne - alprazolam

Buprefarm 25 mikrogram/timme Depotplåster Swedia - Swedia - Läkemedelsverket (Medical Products Agency)

buprefarm 25 mikrogram/timme depotplåster

orifarm generics a/s - buprenorfin - depotplåster - 25 mikrogram/timme - buprenorfin 25 mg aktiv substans

Buprefarm 30 mikrogram/timme Depotplåster Swedia - Swedia - Läkemedelsverket (Medical Products Agency)

buprefarm 30 mikrogram/timme depotplåster

orifarm generics a/s - buprenorfin - depotplåster - 30 mikrogram/timme - buprenorfin 30 mg aktiv substans

Buprefarm 40 mikrogram/timme Depotplåster Swedia - Swedia - Läkemedelsverket (Medical Products Agency)

buprefarm 40 mikrogram/timme depotplåster

orifarm generics a/s - buprenorfin - depotplåster - 40 mikrogram/timme - buprenorfin 40 mg aktiv substans

Pergotime 50 mg Tablett Swedia - Swedia - Läkemedelsverket (Medical Products Agency)

pergotime 50 mg tablett

merck ab - klomifencitrat - tablett - 50 mg - laktosmonohydrat hjälpämne; klomifencitrat 50 mg aktiv substans - klomifen

Zoledronic acid Mylan 5 mg/100 ml Infusionsvätska, lösning Swedia - Swedia - Läkemedelsverket (Medical Products Agency)

zoledronic acid mylan 5 mg/100 ml infusionsvätska, lösning

mylan ab - zoledronsyramonohydrat - infusionsvätska, lösning - 5 mg/100 ml - zoledronsyramonohydrat 5,33 mg aktiv substans; mannitol hjälpämne - zoledronsyra

Bemfola Uni Eropa - Swedia - EMA (European Medicines Agency)

bemfola

gedeon richter plc. - follitropin alfa - anovulation - könshormoner och modulatorer av könsorganen, - in adult women:anovulation (including polycystic ovarian disease, pcod) in women who have been unresponsive to treatment with clomiphene citrate;stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (art) such as in vitro fertilisation (ivf), gamete intra-fallopian transfer (gift) and zygote intra-fallopian transfer (zift);follitropin alfa in association with a luteinising hormone (lh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. i kliniska prövningar dessa patienter definierades av en endogen serum lh nivå < 1. 2 ie / l. in adult men:follitropin alfa is indicated for the stimulation of spermatogenesis in men who have congenital or acquired hypogonadotrophic hypogonadism with concomitant human chorionic gonadotrophin (hcg) therapy.

Zoledronic acid Teva Generics Uni Eropa - Swedia - EMA (European Medicines Agency)

zoledronic acid teva generics

teva generics b.v - zoledronsyramonohydrat - osteoporosis; osteitis deformans - bisfosfonater - behandling av osteoporosisin postmenopausala womenin vuxen menat ökad risk för fraktur, inklusive de med senare låg-trauma höftfraktur. behandling av osteoporos i samband med långvarig systemisk glukokortikoid therapyin postmenopausala womenin vuxen menat ökad risk för fraktur. behandling av pagets sjukdom i ben vuxna.

Zoledronic acid Teva Pharma Uni Eropa - Swedia - EMA (European Medicines Agency)

zoledronic acid teva pharma

teva b.v. - zoledronsyra - osteoporosis; osteitis deformans; osteoporosis, postmenopausal - läkemedel för behandling av bensjukdomar - treatment of osteoporosis: , in post-menopausal women;, in men; , at increased risk of fracture including those with a recent low-trauma hip fracture. treatment of osteoporosis associated with long-term systemic glucocorticoid therapy: , in post-menopausal women;, in men; , at increased risk of fracture. behandling av pagets sjukdom i ben vuxna.